LEX-WK-P7475PGNcrawled 2025-02-13 13:13Z
MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?
Grant Castle · Sarah Cowlishaw · Marie Doyle-Rossi · Raj Gathani · Dan Spivey · Global Policy Watch · Published February 13, 2025
Work details
- author
- Grant Castle · Sarah Cowlishaw · Marie Doyle-Rossi · Raj Gathani · Dan Spivey
- firm or organization
- Covington & Burling LLP
- publication
- Global Policy Watch
- practice area
- Administrative and Regulatory · Health Care and Life Sciences
- published
- 2025-02-13
Citation
Grant Castle, Sarah Cowlishaw, Marie Doyle-Rossi, Raj Gathani, Dan Spivey, MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?, Global Policy Watch (February 13, 2025) [The Library at LexBlog, LEX-WK-P7475PGN, lexpid.org/P7475PGN]